British Journal of Cancer : Impact Factor & More
eISSN: 1532-1827pISSN: 0007-0920
Share this on:
Key Metrics
CiteScore 
12.4
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.89 5-Year SI
SJR
Q1Oncology
SNIP
1.9
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on British Journal of Cancer
British Journal of Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1947 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in British Journal of Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in British Journal of Cancer
Arachidonate lipoxygenase 5 metabolism axis promoting ferroptosis: a potential druggable target for doxorubicin-induced cardiomyopathy.
- 1 Jun 2026
- British journal of cancer
A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT1.
- 1 Jun 2026
- British journal of cancer
Performance of an image-only deep learning breast cancer risk model with the addition of a polygenic risk score.
- 1 Jun 2026
- British journal of cancer
Faecal haemoglobin-based referral and investigation prioritisation is associated with colorectal cancer-specific survival in symptomatic patients: a retrospective observational study.
- 1 Jun 2026
- British journal of cancer
Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC.
- 1 Jun 2026
- British journal of cancer
Molecular phenotypes stratify small cell lung cancer for targeted therapy and immunotherapy.
- 1 Jun 2026
- British journal of cancer
Arachidonate lipoxygenase 5 metabolism axis promoting ferroptosis: a potential druggable target for doxorubicin-induced cardiomyopathy.
- 1 Jun 2026
- British journal of cancer
A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT1.
- 1 Jun 2026
- British journal of cancer
Performance of an image-only deep learning breast cancer risk model with the addition of a polygenic risk score.
- 1 Jun 2026
- British journal of cancer
Faecal haemoglobin-based referral and investigation prioritisation is associated with colorectal cancer-specific survival in symptomatic patients: a retrospective observational study.
- 1 Jun 2026
- British journal of cancer
Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC.
- 1 Jun 2026
- British journal of cancer
Molecular phenotypes stratify small cell lung cancer for targeted therapy and immunotherapy.
- 1 Jun 2026
- British journal of cancer
FAQs on British Journal of Cancer
How long has British Journal of Cancer been actively publishing? 
What is the publishing frequency of British Journal of Cancer?
How many articles did British Journal of Cancer publish last year?
What is the eISSN & pISSN for British Journal of Cancer?
What is Citescore for British Journal of Cancer?
What is SNIP score for British Journal of Cancer?
What is the SJR for British Journal of Cancer?
Who is the publisher of British Journal of Cancer?
